What is Praluent’s official list price for 2026?
I can’t determine Praluent’s 2026 “official list price” from the information provided here because no pricing source or 2026 price data is included.
Where do people usually find the “official list price” for Praluent?
Searchers typically look for Praluent list pricing in sources such as:
- the drug’s U.S. official list price as published by pricing datasets or drug pricing tools, and/or
- the manufacturer’s published pricing materials (where available), and/or
- the Centers for Medicare & Medicaid Services (CMS) drug pricing files (commonly used for reference pricing).
Is “list price” the number patients actually pay?
No. Even when you find a “list price,” what a patient pays can differ a lot due to:
- insurance coverage and negotiated rebates,
- pharmacy benefit manager (PBM) discounts,
- copay cards or patient assistance programs (if eligible),
- whether the patient is billed under commercial vs. government pricing systems.
If you share your country and dose, I can help narrow the right price
To look up the correct 2026 list price figure, I need at least:
- country (U.S. vs. another market),
- dose/strength (e.g., 75 mg vs. 150 mg),
- formulation (pre-filled pen vs. syringe, if applicable),
- and whether you mean per pen, per month, or per vial/box.
If you tell me those details (or paste the price source you’re using), I can help verify what number corresponds to “official list price” and how to interpret it.